References
- Bulun SE, Yang S, Fang Z, Gurates B, Tamura M, Zhou J, et al. 2001. Role of aromatase in endometrial disease. Journal of Steroid Biochemistry and Molecular Biology 79: 19–25.
- Feeley KM, Wells M. 2001. Hormone replacement therapy and the endometrium. Journal of Clinical Pathology 54: 435–440.
- Fishman A, Demirel D, Laucirica R, Ramzy I, Kilma T, Lyzak J, et al. 1996. Malignant tumours arising in endometriosis: clinical-pathological study and flow cytometry analysis. European Journal of Obstetrics, Gynecology and Reproductive Biology 70: 69–74 .
- Gucer F, Pieber D, Arikan MG. 1998. Malignancy arising in extraovarian endometriosis during oestrogen stimulation. Eur-opean Journal of Gynaecological Oncology 19: 39–41.
- Han AC, Hovenden S, Rosenblum NC, Salazar H. 1998. Adenocarcinoma arising in extragonodal endometriosis: an immunohistchemical study. Cancer 83: 1163–1169.
- Mahmood TA, Templeton A. 1991. Prevalence and genesis of endometriosis. Human Reproduction 6: 544–549.
- Martini M, Ciccarone M, Garganese G, Maggiore C, Evangelista A, Rahimi S. et al. 2002. Possible involvement of hIVILH1, p16(INK4a) and PTEN in the malignant transformation of endometriosis. International Journal of Cancer 102: 398–406.
- Stern RC, Dash R, Bentley RC, Synder MJ, Haney AF, Robboy SJ. 2001. Malignancy in endometriosis: frequency and compar-ison of ovarian and extraovarian types. International Journal of Gynaecological Pathology 20: 135–139.
- Ulrich U, Richter 0, Wardelmann E, Valter M, Schmutzler R, Sillem M, et al. 2003.
- Endometriosis and malignoma. Zentral-blatt fur Gynakologie 125: 239–242.